These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25377370)

  • 21. [Serotonin neurotrasmission and treatment options for depression].
    Sivolap YP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):174-177. PubMed ID: 29265105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polysomnographic effects of hypnotic drugs. A review.
    Parrino L; Terzano MG
    Psychopharmacology (Berl); 1996 Jul; 126(1):1-16. PubMed ID: 8853211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The use of zopiclone for correction of elevated blood pressure in elderly patients with essential hypertension and insomnia].
    Martynov AI; Veĭn AM; Ostroumova OD; Eligulashvili TS; Mamaev VI; Novinskiĭ AA
    Kardiologiia; 2002; 42(8):11-4. PubMed ID: 12494087
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of eszopiclone in the treatment of insomnia.
    Morin AK; Willett K
    Adv Ther; 2009 May; 26(5):500-18. PubMed ID: 19513631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zopiclone use during pregnancy.
    Diav-Citrin O; Okotore B; Lucarelli K; Koren G
    Can Fam Physician; 2000 Jan; 46():63-4. PubMed ID: 10660786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical management of patients with insomnia. The role of zopiclone.
    Hajak G; Rodenbeck A
    Pharmacoeconomics; 1996; 10 Suppl 1():29-38. PubMed ID: 10163425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial.
    Soares CN; Joffe H; Rubens R; Caron J; Roth T; Cohen L
    Obstet Gynecol; 2006 Dec; 108(6):1402-10. PubMed ID: 17138773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative evaluation of the hypnotic drugs under conditions of brain injury].
    Belozertsev IuA; Shchelkanova OA; Belozertsev FIu; Iuntsev SV
    Eksp Klin Farmakol; 2012; 75(8):31-3. PubMed ID: 23012993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression.
    Krystal A; Fava M; Rubens R; Wessel T; Caron J; Wilson P; Roth T; McCall WV
    J Clin Sleep Med; 2007 Feb; 3(1):48-55. PubMed ID: 17557453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zopiclone in the treatment of insomnia: an open clinical trial.
    Disayavanish C; Srisurapanont M; Disayavanish P
    J Med Assoc Thai; 1998 Jun; 81(6):393-6. PubMed ID: 9676070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypnotic discontinuation in chronic insomnia: impact of psychological distress, readiness to change, and self-efficacy.
    Belleville G; Morin CM
    Health Psychol; 2008 Mar; 27(2):239-48. PubMed ID: 18377143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of insomnia - effect of trazodone and hypnotics on sleep.
    Wichniak A; Wierzbicka AE; Jarema M
    Psychiatr Pol; 2021 Aug; 55(4):743-755. PubMed ID: 34994734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health-related quality of life in patients with insomnia treated with zopiclone.
    Leger D; Quera-Salva MA; Philip P
    Pharmacoeconomics; 1996; 10 Suppl 1():39-44. PubMed ID: 10163426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zolpidem for persistent insomnia in SSRI-treated depressed patients.
    Asnis GM; Chakraburtty A; DuBoff EA; Krystal A; Londborg PD; Rosenberg R; Roth-Schechter B; Scharf MB; Walsh JK
    J Clin Psychiatry; 1999 Oct; 60(10):668-76. PubMed ID: 10549683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zopiclone: a non-benzodiazepine hypnotic. Controlled comparison to temazepam in insomnia.
    Wheatley D
    Br J Psychiatry; 1985 Mar; 146():312-4. PubMed ID: 2859069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effectiveness of zopiclone in disorders of initiating and maintaining sleep. Results of a drug monitoring study in 811 general practices].
    Wiegand MH; Roszinsky-Köcher G; Schwalb B; Fischer W; Eckert MW
    Fortschr Med Orig; 2001; 119(1):25-32. PubMed ID: 11935654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Withdrawal from long-term use of zopiclone, zolpidem and temazepam may improve perceived sleep and quality of life in older adults with primary insomnia.
    Lähteenmäki R; Neuvonen PJ; Puustinen J; Vahlberg T; Partinen M; Räihä I; Kivelä SL
    Basic Clin Pharmacol Toxicol; 2019 Mar; 124(3):330-340. PubMed ID: 30295409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.
    Pollack M; Kinrys G; Krystal A; McCall WV; Roth T; Schaefer K; Rubens R; Roach J; Huang H; Krishnan R
    Arch Gen Psychiatry; 2008 May; 65(5):551-62. PubMed ID: 18458207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In brief: lowering the dose of Lunesta.
    Med Lett Drugs Ther; 2014 Jun; 56(1444):48. PubMed ID: 24933089
    [No Abstract]   [Full Text] [Related]  

  • 40. Correlates of dependence and beliefs about the use of hypnotics among zolpidem and zopiclone users.
    Yen CF; Yen CN; Ko CH; Hwang TJ; Chen CS; Chen TT; Su PW; Chen ST; Lin JJ
    Subst Use Misuse; 2015 Feb; 50(3):350-7. PubMed ID: 25458710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.